Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

Clofutriben Pharmacokinetics in Patients With Impaired Renal Function

Sparrow Pharmaceuticals · NCT07227922

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–83 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
16
US sites recruiting
1
Study start
November 30, 2025
Record last updated
December 23, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a Phase 1, single-center, open-label, single-dose trial. Sixteen participants are planned: 8 participants with moderate renal impairment and 8 matched control participants with normal renal function.

Being studied: 12mg clofutriben

Conditions: Moderate Renal Impairment

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Male and female participants with stable moderate renal impairment (estimated glomerular filtration rate [eGFR]: 30 to \<60 mL/min) and matched (by sex, age, and weight) control participants with normal renal function (eGFR: ≥90 mL/min) will be enrolled in this trial.

Exclusion Criteria

  • Participant whose current or recent medical conditions, medications, or procedures could increase participant's safety risk, or whom the Investigator considers not suitable for entry into the trial or the participant, or who has clinically significant abnormal 12-lead electrocardiogram (ECG)/ vital sign measurements/ laboratory test results at Screening and Check-in, will not be enrolled

Recruiting US locations

  • Orlando Clinical Research Center

    Orlando, FL 32809

    Site contact: Rhyan Clinical Research Manager · 407.472.0225 · rdumontlorenzo@ocrc.net

Clofutriben Pharmacokinetics in Patients With Impaired Renal Function (NCT07227922) | Bored Studies